BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Emergent BioSolutions 

2273 Research Boulevard
Suite 400
Rockville  Maryland  20850  U.S.A.
Phone: 301-795-1800 Fax: 301-795-1899


SEARCH JOBS
Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Emergent’s marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine licensed by the U.S. Food and Drug Administration for the prevention of anthrax infection. Emergent’s development pipeline includes programs focused on anthrax, botulism, tuberculosis, typhoid, hepatitis B and chlamydia.


 Key Statistics


Email:
Ownership: Public

Web Site: Emergent BioSolutions
Employees:
Symbol: EBS
 









 Company News
Emergent BioSolutions (EBS) To Release First Quarter 2014 Financial Results And Conduct A Conference Call On May 8, 2014 4/23/2014 7:14:13 AM    More...
Emergent BioSolutions (EBS) And FDA Finalize Comparability Protocols Enabling Manufacturing Of Biothrax Consistency Lots In Building 55 4/22/2014 8:05:22 AM    More...
Emergent BioSolutions (EBS) Receives Orphan Drug Designation For BioThrax For Post-Exposure Prophylaxis Of Anthrax Disease 4/21/2014 9:40:23 AM    More...
Emergent BioSolutions (EBS) To Participate In May 2014 Investor Conferences 4/17/2014 6:55:33 AM    More...
Emergent BioSolutions (EBS) Successfully Completes Pivotal Clinical Study To Support Expanded Indication For BioThrax 4/16/2014 9:08:41 AM    More...
Emergent BioSolutions (EBS) Reports Financial Results For 2013 3/7/2014 6:45:43 AM    More...
Biodel Inc. (BIOD) Announces Commercial Manufacturing Agreement With Emergent BioSolutions (EBS) For Glucagon Rescue Product 3/6/2014 9:31:11 AM    More...
Emergent BioSolutions (EBS) To Release Fourth Quarter And Full Year 2013 Financial Results And Conduct A Conference Call On March 6, 2014 3/3/2014 7:25:34 AM    More...
Emergent BioSolutions (EBS) Completes Acquisition Of Cangene Corporation (CC:CNJ) 2/21/2014 9:36:17 AM    More...
Emergent BioSolutions (EBS) To Webcast Presentations At February And March 2014 Investor Conferences 2/3/2014 8:51:48 AM    More...
12345678910...

//-->